相似文献
1
Editorial: gut microbial profile associated with primary sclerosing cholangitis-what is new and how do we progress from here? Authors' reply.
Aliment Pharmacol Ther. 2019 Sep;50(5):606-607. doi: 10.1111/apt.15434.
2
Editorial: gut microbial profile associated with primary sclerosing cholangitis-what is new and how do we progress from here?
Aliment Pharmacol Ther. 2019 Sep;50(5):605-606. doi: 10.1111/apt.15424.
3
The gut microbial profile in patients with primary sclerosing cholangitis is distinct from patients with ulcerative colitis without biliary disease and healthy controls.
Gut. 2017 Apr;66(4):611-619. doi: 10.1136/gutjnl-2015-310500. Epub 2016 Feb 17.
4
Distinct gut microbiota profiles in patients with primary sclerosing cholangitis and ulcerative colitis.
World J Gastroenterol. 2017 Jul 7;23(25):4548-4558. doi: 10.3748/wjg.v23.i25.4548.
5
Characterisation of the faecal microbiota in Japanese patients with paediatric-onset primary sclerosing cholangitis.
Gut. 2017 Jul;66(7):1344-1346. doi: 10.1136/gutjnl-2016-312533. Epub 2016 Sep 26.
6
Manipulation of the Gut-Liver Axis Using Microbiome Restoration Therapy in Primary Sclerosing Cholangitis.
Am J Gastroenterol. 2019 Jul;114(7):1027-1029. doi: 10.14309/ajg.0000000000000191.
7
Gut microbiota in PSC : From association to possible causality. Commentary to "Gut pathobionts underlie intestinal barrier dysfunction and liver T helper 17 cell immune response in primary sclerosing cholangitis" by Nakamoto et al., Nature Microbiology, January 2019.
Clin Res Hepatol Gastroenterol. 2020 Apr;44(2):123-125. doi: 10.1016/j.clinre.2019.06.005. Epub 2019 Jun 28.
8
Oral vancomycin induces clinical and mucosal remission of colitis in children with primary sclerosing cholangitis-ulcerative colitis.
Gut. 2019 Aug;68(8):1533-1535. doi: 10.1136/gutjnl-2018-316599. Epub 2018 Aug 21.
9
The Microbiome and Primary Sclerosing Cholangitis.
Semin Liver Dis. 2016 Sep;36(4):340-348. doi: 10.1055/s-0036-1594007. Epub 2016 Dec 20.
10
The features of mucosa-associated microbiota in primary sclerosing cholangitis.
Aliment Pharmacol Ther. 2016 Apr;43(7):790-801. doi: 10.1111/apt.13552. Epub 2016 Feb 9.
本文引用的文献
1
Editorial: gut microbial profile associated with primary sclerosing cholangitis-what is new and how do we progress from here?
Aliment Pharmacol Ther. 2019 Sep;50(5):605-606. doi: 10.1111/apt.15424.
2
Consistent alterations in faecal microbiomes of patients with primary sclerosing cholangitis independent of associated colitis.
Aliment Pharmacol Ther. 2019 Sep;50(5):580-589. doi: 10.1111/apt.15375. Epub 2019 Jun 28.
3
Multi-omics of the gut microbial ecosystem in inflammatory bowel diseases.
Nature. 2019 May;569(7758):655-662. doi: 10.1038/s41586-019-1237-9. Epub 2019 May 29.
4
The Integrative Human Microbiome Project.
Nature. 2019 May;569(7758):641-648. doi: 10.1038/s41586-019-1238-8. Epub 2019 May 29.
5
Fungi participate in the dysbiosis of gut microbiota in patients with primary sclerosing cholangitis.
Gut. 2020 Jan;69(1):92-102. doi: 10.1136/gutjnl-2018-317791. Epub 2019 Apr 19.
6
Gut pathobionts underlie intestinal barrier dysfunction and liver T helper 17 cell immune response in primary sclerosing cholangitis.
Nat Microbiol. 2019 Mar;4(3):492-503. doi: 10.1038/s41564-018-0333-1. Epub 2019 Jan 14.
7
The Human-Associated Archaeon Is Recognized through Its RNA and Induces TLR8-Dependent NLRP3 Inflammasome Activation.
Front Immunol. 2017 Nov 13;8:1535. doi: 10.3389/fimmu.2017.01535. eCollection 2017.
8
First Insights into the Diverse Human Archaeome: Specific Detection of Archaea in the Gastrointestinal Tract, Lung, and Nose and on Skin.
mBio. 2017 Nov 14;8(6):e00824-17. doi: 10.1128/mBio.00824-17.
Zotero 插件